Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #301 to #350.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 3rd transcript block in Natural Assets documentary (Q16330)‏‎ (35 links)
  2. Modern medicine : its theory and practice, in original contributions by American and foreign authors (1907-1910.). Volume 1 from t54f2j58c (Q11415)‏‎ (35 links)
  3. 23rd transcript block in Roses of Crimson documentary (Q14862)‏‎ (35 links)
  4. Methods (Q7979)‏‎ (35 links)
  5. American Football Game (Q229)‏‎ (35 links)
  6. 15th transcript block in Roses of Crimson documentary (Q14854)‏‎ (35 links)
  7. location (P49)‏‎ (34 links)
  8. Offensive Lineman (Q1353)‏‎ (34 links)
  9. 5th transcript block in Roses of Crimson documentary (Q14844)‏‎ (34 links)
  10. Cites Publication (P109)‏‎ (34 links)
  11. Dr. Ruth Underhill (Q6230)‏‎ (33 links)
  12. 16th transcript block in Miller's Pottery: Turning for Generations documentary (Q16001)‏‎ (33 links)
  13. End of Half (Q27)‏‎ (33 links)
  14. Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8471)‏‎ (32 links)
  15. Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8479)‏‎ (32 links)
  16. Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8487)‏‎ (32 links)
  17. Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8463)‏‎ (32 links)
  18. Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8464)‏‎ (32 links)
  19. Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8472)‏‎ (32 links)
  20. Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8480)‏‎ (32 links)
  21. Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) (Q8488)‏‎ (32 links)
  22. Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8465)‏‎ (32 links)
  23. Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) (Q8473)‏‎ (32 links)
  24. Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8481)‏‎ (32 links)
  25. Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5) (Q8489)‏‎ (32 links)
  26. Robert Foster (Q1366)‏‎ (32 links)
  27. Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8466)‏‎ (32 links)
  28. Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8474)‏‎ (32 links)
  29. Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8482)‏‎ (32 links)
  30. Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) (Q8490)‏‎ (32 links)
  31. Bibliography (from DOI: 10.1038/s41392-020-0110-5) (Q10035)‏‎ (32 links)
  32. Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8467)‏‎ (32 links)
  33. Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8475)‏‎ (32 links)
  34. Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8483)‏‎ (32 links)
  35. Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5) (Q8491)‏‎ (32 links)
  36. Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8468)‏‎ (32 links)
  37. Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8476)‏‎ (32 links)
  38. Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8484)‏‎ (32 links)
  39. Competing interests (from DOI: 10.1038/s41392-020-0110-5) (Q8492)‏‎ (32 links)
  40. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) (DOI: 10.1080/22221751.2020.1735265)‏‎ (32 links)
  41. Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8469)‏‎ (32 links)
  42. Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8477)‏‎ (32 links)
  43. Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8485)‏‎ (32 links)
  44. 9th transcript block in Miller's Pottery: Turning for Generations documentary (Q15994)‏‎ (32 links)
  45. Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8470)‏‎ (32 links)
  46. Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8478)‏‎ (32 links)
  47. Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5) (Q8486)‏‎ (32 links)
  48. Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5) (Q8462)‏‎ (32 links)
  49. Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5)‏‎ (31 links)
  50. Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5)‏‎ (31 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:MostLinkedPages"